As modern medicine enters the nanoera, a silent revolution is underway-a biodegradable chip, barely the size of a grain of rice, is rewriting the history of humanity's fight against heart disease. On April 2, 2025, a Northwestern University research team published their latest research findings in Nature. Their millimeter-scale bioabsorbable optoelectronic device, like a magic key, unlocks new solutions to numerous medical challenges.
The Achilles' Heel of Traditional Pacemakers
In medical settings, temporary pacemakers are undoubtedly a vital safeguard for maintaining vital rhythms for patients experiencing short-term bradycardia. However, traditional temporary pacemakers present numerous challenges during their use. Whether using invasive, open-chest surgery to place the pacemaker lead or vascular placement, each presents its own set of challenges. Vascular placement is not suitable for children or patients unsuitable for vascular implants. Furthermore, both methods are prone to complications such as foreign body rejection, long-term battery dependency, and significant surgical trauma. These issues, like heavy shackles, limit the effectiveness of temporary pacemakers and impose significant pain and risks on patients.
Innovative Breakthrough: The Birth of a Millimeter-Scale Degradable Pacemaker
Facing the challenges of traditional temporary pacemakers, a research team, through tireless exploration, has successfully developed a remarkable, injectable and degradable miniature temporary pacemaker. Measuring only 1.8 mm × 3.5 mm × 1 mm, it's as compact as a grain of rice. This tiny body packs immense power, offering significant advantages. First, the ultra-small size supports minimally invasive implantation, greatly reducing the burden of the device on the patient's body and the risks of implantation surgery. More importantly, it provides special groups such as newborns with the possibility of receiving treatment.
The core technology behind this groundbreaking research lies in the organic integration of microbatteries, photoelectric sensors, and biological tissue. Unlike traditional pacemakers, which require pacing leads connected to an independent power source, this new device uses battery electrodes directly as pacing electrodes and utilizes human body fluids/tissue as electrolytes, enabling self-powering after implantation. It requires no external energy source for independent operation, simplifying its use and reducing the risks associated with external power sources.
The device also incorporates a microphotoswitch, allowing researchers to remotely and wirelessly control the pacemaker using 850nm near-infrared light to precisely regulate heart rhythm. This light source, placed on the skin surface above the heart, can control pacemakers implanted less than 6 cm deep. Furthermore, an external wearable skin patch designed by Professor Wei Ouyang of Dartmouth College not only provides programmable near-infrared light for pacemaker control but also collects and analyzes electrocardiogram (ECG) data for real-time intelligent heart rhythm monitoring. Upon detecting an anomaly, it automatically activates near-infrared light to activate the pacemaker, achieving fully autonomous closed-loop control of the system.
To verify the effectiveness of the system's cardiac pacing, the research team conducted a large number of rigorous experiments and successfully completed controllable pacing in cardiac models of mice, rats, pigs, dogs (in vivo) and humans (in vitro), using data and practice to demonstrate the device's excellent performance.
Notably, the device does not remain permanently in the body. Its components are made of biodegradable and resorbable materials. After successfully completing its cardiac pacing mission, it gradually degrades within the body. These degradation products are excreted through the kidneys over a period of 1 to 2.5 years. This feature completely eliminates the need for a secondary surgery to remove the device, further reducing the risk of device use and representing a major advancement in medical technology.
Clinical Outlook: Diverse Applications Bring New Hope
From a clinical application perspective, this millimeter-scale bioabsorbable optoelectronic device demonstrates tremendous potential. When paired with a skin-mounted device, it can rapidly initiate autonomous closed-loop cardiac electrotherapy upon detection of arrhythmias, providing timely and effective treatment for patients with arrhythmias. Furthermore, when integrated with a transcatheter aortic valve replacement (TAVR) system, it can provide rapid pacing during valve implantation, ensuring a smooth procedure, and routine pacing afterward, aiding patient recovery.
This research, integrating cutting-edge technologies from multiple disciplines, including battery technology, optoelectronics, micro-nanofabrication, and biocompatible materials, has successfully developed a next-generation pacemaker. It not only significantly advances the development of implantable cardiovascular devices, bringing new hope to many patients, but also provides valuable new insights into future implantable devices and tissue-penetrating wireless control. This novel "non-invasive, intelligent, and autonomously powered" implantable device model opens up vast new avenues for development in precision medicine, potentially reshaping the healthcare landscape and contributing to a more prosperous future for human health. I believe that in the near future, with the continuous improvement and promotion of technology, this innovative achievement will benefit more patients and become an important milestone in the history of medical technology.
